Lysogene S.A.

BATS-CHIXE:LYSP Stock Report

Market Cap: €11.4m

Lysogene Management

Management criteria checks 2/4

Lysogene's CEO is Karen Pignet-Aiach, appointed in Jan 2009, has a tenure of 13.5 years. directly owns 2.28% of the company’s shares, worth €259.85K. The average tenure of the management team and the board of directors is 3.5 years and 4 years respectively.

Key information

Karen Pignet-Aiach

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13.5yrs
CEO ownership2.3%
Management average tenure3.5yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Karen Pignet-Aiach's remuneration changed compared to Lysogene's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2021n/an/a

-€14m

Sep 30 2021n/an/a

-€12m

Jun 30 2021n/an/a

-€11m

Mar 31 2021n/an/a

-€8m

Dec 31 2020€3m€320k

-€5m

Sep 30 2020n/an/a

-€4m

Jun 30 2020n/an/a

-€2m

Mar 31 2020n/an/a

-€3m

Dec 31 2019€829k€320k

-€4m

Sep 30 2019n/an/a

-€5m

Jun 30 2019n/an/a

-€6m

Mar 31 2019n/an/a

-€8m

Dec 31 2018€1m€310k

-€11m

Sep 30 2018n/an/a

-€14m

Jun 30 2018n/an/a

-€17m

Mar 31 2018n/an/a

-€17m

Dec 31 2017€981k€310k

-€18m

Sep 30 2017n/an/a

-€15m

Jun 30 2017n/an/a

-€13m

Mar 31 2017n/an/a

-€10m

Dec 31 2016€3m€280k

-€7m

Sep 30 2016n/an/a

-€6m

Jun 30 2016n/an/a

-€5m

Mar 31 2016n/an/a

-€5m

Dec 31 2015€308k€240k

-€4m

Compensation vs Market: Insufficient data to establish whether Karen's total compensation is reasonable compared to companies of similar size in the UK market.

Compensation vs Earnings: Karen's compensation has increased whilst the company is unprofitable.

CEO

Karen Pignet-Aiach (51 yo)

13.5yrs

Tenure

€2,588,100

Compensation

Mrs. Karen Pignet-Aiach, MBA, has been Chairman of Lysogene S.A. since May 22, 2019 and is its Chief Executive Officer since May 20, 2019. Mrs. Pignet-Aiach serves as Chief Executive Officer and Director o...

Leadership Team

NamePositionTenureCompensationOwnership
Karen Pignet-Aiach
Founder13.5yrs€2.59m2.28%
€ 259.9k
Stephane des Aulnois
Administrative & Financial Director2.8yrsno datano data
Ralph Laufer
Chief Scientific Officer4.2yrsno datano data
Michaël Hocquemiller
Head of Non-Clinical Developmentno datano datano data
Marie Deneux
Chief Regulatory affairs3.5yrsno datano data
Marie Trad
Chief Clinical Officerless than a yearno datano data

3.5yrs

Average Tenure

Experienced Management: LYSP's management team is considered experienced (3.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Karen Pignet-Aiach
Founder3.2yrs€2.59m2.28%
€ 259.9k
Philippe Goupit
Non-Executive Independent Director3.8yrs€40.00kno data
David Schilansky
Non-Executive Independent Director5.7yrs€45.00kno data
Peter Lichtlen
Non-Executive Independent Director4.3yrs€40.00kno data
Mathieu Simon
Non-Executive Independent Director3.2yrs€35.00kno data
Ronald Crystal
Member of Clinical Advisory Board4.8yrsno datano data
Steven Gray
Member of Scientific Advisorsno datano datano data
Chester Whitley
Member of Clinical Advisory Board4.8yrsno datano data
Carole Deffez
Non-Executive Independent Director2.8yrs€45.00kno data
Nathalie Cartier-Lacave
Member of Scientific Advisorno datano datano data

4.0yrs

Average Tenure

53yo

Average Age

Experienced Board: LYSP's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/07/04 18:55
End of Day Share Price 2022/04/06 00:00
Earnings2021/12/31
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lysogene S.A. is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eric Le BerrigaudBryan Garnier & Co
Lea De CabezonGilbert Dupont
Delphine Le LouetSociete Generale Cross Asset Research